Avalo Therapeutics Statistics

Total Valuation

AVTX has a market cap or net worth of $42.69 million. The enterprise value is -$82.36 million.

Market Cap	42.69M
Enterprise Value	-82.36M

Important Dates

The last earnings date was Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

AVTX has 10.67 million shares outstanding. The number of shares has increased by 1,963.31% in one year.

Current Share Class	10.67M
Shares Outstanding	10.67M
Shares Change (YoY)	+1,963.31%
Shares Change (QoQ)	+2.81%
Owned by Insiders (%)	5.94%
Owned by Institutions (%)	20.76%
Float	3.68M

Valuation Ratios

The trailing PE ratio is 0.58.

PE Ratio	0.58
Forward PE	n/a
PS Ratio	62.04
Forward PS	n/a
PB Ratio	0.35
P/TBV Ratio	0.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.61

Current Ratio	22.61
Quick Ratio	22.27
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 678.24% and return on invested capital (ROIC) is -269.26%.

Return on Equity (ROE)	678.24%
Return on Assets (ROA)	-23.98%
Return on Invested Capital (ROIC)	-269.26%
Return on Capital Employed (ROCE)	-37.85%
Revenue Per Employee	$19,174
Profits Per Employee	$3.17M
Employee Count	23
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, AVTX has paid $115,000 in taxes.

Income Tax	115,000
Effective Tax Rate	0.16%

Stock Price Statistics

The stock price has decreased by -63.13% in the last 52 weeks. The beta is 0.88, so AVTX's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	-63.13%
50-Day Moving Average	6.19
200-Day Moving Average	8.67
Relative Strength Index (RSI)	28.50
Average Volume (20 Days)	68,443

Short Selling Information

The latest short interest is 45,497, so 0.43% of the outstanding shares have been sold short.

Short Interest	45,497
Short Previous Month	100,390
Short % of Shares Out	0.43%
Short % of Float	1.24%
Short Ratio (days to cover)	0.77

Income Statement

In the last 12 months, AVTX had revenue of $441,000 and earned $73.01 million in profits.

Revenue	441,000
Gross Profit	-14.92M
Operating Income	-50.31M
Pretax Income	-142.87M
Net Income	73.01M
EBITDA	-50.04M
EBIT	-50.31M
Earnings Per Share (EPS)	-$4.90

Full Income Statement

Balance Sheet

The company has $125.05 million in cash and n/a in debt, giving a net cash position of $125.05 million or $11.72 per share.

Cash & Cash Equivalents	125.05M
Total Debt	n/a
Net Cash	125.05M
Net Cash Per Share	$11.72
Equity (Book Value)	122.62M
Book Value Per Share	11.32
Working Capital	121.33M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-52.31M
Capital Expenditures	n/a
Free Cash Flow	-52.31M
FCF Per Share	-$4.90

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-11,408.39%
Pretax Margin	16,582.09%
Profit Margin	16,556.01%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,963.31%
Shareholder Yield	-1,963.31%
Earnings Yield	171.04%
FCF Yield	-122.54%

Analyst Forecast

The average price target for AVTX is $34.20, which is 755.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.20
Price Target Difference	755.00%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	82.86%
EPS Growth Forecast (5Y)	-28.78%

Stock Forecasts

Stock Splits

The last stock split was on December 29, 2023. It was a reverse split with a ratio of 0.0041667:1.

Last Split Date	Dec 29, 2023
Split Type	Reverse
Split Ratio	0.0041667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2